Abstract:figure legend Human intestinal organoids were genetically modified to express a fluorescent protein in enteroendocrine cells (EECs), which were then separated by flow cytometry and analysed by single‐cell RNA sequencing. High numbers of human EECs were thereby available for cluster analysis and differential gene expression, revealing transcriptomic differences between EEC populations. Gut hormones control intestinal function, metabolism and appetite, and have been harnessed therapeutically to treat type 2 diabetes and obesity. Our understanding of the enteroendocrine axis arises largely from animal studies, but intestinal organoid models make it possible to identify, genetically modify and purify human enteroendocrine cells (EECs). This study aimed to map human EECs using single‐cell RNA sequencing. Organoids derived from human duodenum and ileum were genetically modified using CRISPR‐Cas9 to express the fluorescent protein Venus driven by the chromogranin‐A promoter. Fluorescent cells from CHGA‐Venus organoids were purified by flow cytometry and analysed by 10X single‐cell RNA sequencing. Cluster analysis separated EEC populations, allowing an examination of differentially expressed hormones, nutrient‐sensing machinery, transcription factors and exocytotic machinery. Bile acid receptor GPBAR1 was most highly expressed in L‐cells (producing glucagon‐like peptide 1 and peptide YY), long‐chain fatty acid receptor FFAR1 was highest in I‐cells (cholecystokinin), K‐cells (glucose‐dependent insulinotropic polypeptide) and L‐cells, short‐chain fatty acid receptor FFAR2 was highest in ileal L‐cells and enterochromaffin cells, olfactory receptor OR51E1 was notably expressed in ileal enterochromaffin cells, and the glucose‐sensing sodium glucose cotransporter SLC5A1 was highly and differentially expressed in K‐ and L‐cells, reflecting their known responsiveness to ingested glucose. The organoid EEC atlas was merged with published data from human intestine and organoids, with good overlap between enteroendocrine datasets. Understanding the similarities and differences between human EEC types will facilitate the development of drugs targeting the enteroendocrine axis for the treatment of conditions such as diabetes, obesity and intestinal disorders. Key points Gut hormones regulate intestinal function, nutrient homeostasis and metabolism and form the basis of the new classes of drugs for obesity and diabetes. As enteroendocrine cells (EECs) comprise only ∼1% of the intestinal epithelium, they are under‐represented in current single‐cell atlases. To identify, compare and characterise human EECs we generated chromogranin‐A labelled organoids from duodenal and ileal biopsies by CRISPR‐Cas9. Fluorescent chromogranin‐A positive EECs were purified and analysed by single‐cell RNA sequencing, revealing predominant cell clusters producing different gut hormones. Cell clusters exhibited differential expression of nutrient‐sensing machinery including bile acid receptors, long‐ and short‐chain fatty acid receptors and glucose transporters. Organoid‐derived EECs mapped well onto data from native intestinal cell populations, extending coverage of EECs.

Human Intestinal Enteroids With Inducible Neurogenin-3 Expression as a Novel Model of Gut Hormone Secretion

High-Resolution mRNA and Secretome Atlas of Human Enteroendocrine Cells

Human Enteroids As A Model of Upper Small Intestinal Ion Transport Physiology and Pathophysiology

Enhancing responsiveness of human jejunal enteroids to host and microbial stimuli

Single‐cell transcriptomics of human organoid‐derived enteroendocrine cell populations from the small intestine

Single cell transcriptomic profiling of large intestinal enteroendocrine cells in mice - Identification of selective stimuli for insulin-like peptide-5 and glucagon-like peptide-1 co-expressing cells

Robust differentiation of human enteroendocrine cells from intestinal stem cells

Mapping the druggable targets displayed by human colonic enteroendocrine cells

Single-cell transcriptomic atlas of enteroendocrine cells along the murine gastrointestinal tract

Description and functional validation of human enteroendocrine cell sensors

In Vitro Enteroid-Derived Three-Dimensional Tissue Model of Human Small Intestinal Epithelium with Innate Immune Responses.

An Approach to Intersectionally Target Mature Enteroendocrine Cells in the Small Intestine of Mice

DRG-Derived Neural Progenitors Differentiate into Functional Enteric Neurons Following Transplantation in the Postnatal Colon.

Human Intestinal Enteroids Model MHC-II in the Gut Epithelium

Premigratory Neural Crest Stem Cells Generate Enteric Neurons Populating the Mouse Colon and Regulating Peristalsis in Tissue-Engineered Intestine

Enteroendocrine Cells Protect the Stem Cell Niche by Regulating Crypt Metabolism in Response to Nutrients

The Imperative for Innovative Enteric Nervous System-Intestinal Organoid Co-Culture Models: Transforming GI Disease Modeling and Treatment

Isolation of Myenteric and Submucosal Plexus from Mouse Gastrointestinal Tract and Subsequent Co-Culture with Small Intestinal Organoids

Intestinal Epithelial Barrier Maturation by Enteric Glial Cells Is GDNF-Dependent

Bioengineered in Vitro Enteric Nervous System.

Transplanted ENSCs form functional connections with intestinal smooth muscle and restore colonic motility in nNOS-deficient mice